{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:00:32Z","timestamp":1795147232937,"version":"4.10.3"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020612","name":"Kalinga Institute of Industrial Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021112","name":"Utkal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020052","name":"National Centre for Cell Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117177","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T03:21:37Z","timestamp":1721791297000},"page":"117177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":542,"special_numbering":"C","title":["The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds"],"prefix":"10.1016","volume":"178","author":[{"given":"Nitish Kumar","family":"Bhol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhabi Madhusmita","family":"Bhanjadeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh Chandra","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Ranjan","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanatan","family":"Majhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim K.","family":"Duttaroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atala Bihari","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117177_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0008-8749(74)90066-5","article-title":"Similarities of T cell function in cell-mediated immunity and antibody production","volume":"12","author":"Cohen","year":"1974","journal-title":"Cell. Immunol."},{"issue":"2004","key":"10.1016\/j.biopha.2024.117177_bib2","first-page":"242","article-title":"Cytokine: more than a new word, a new concept proposed by Stanley Cohen thirty years ago","volume":"28","author":"Cohen","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2024.117177_bib3","unstructured":"W.E. Paul, Fundamental immunology [CD]\/edited by William E. Paul., (1999)."},{"key":"10.1016\/j.biopha.2024.117177_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0031-6997(24)01470-4","article-title":"The sympathetic nerve\u2014an integrative interface between two supersystems: the brain and the immune system","volume":"52","author":"Elenkov","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2024.117177_bib5","series-title":"Nijkamp and Parnham\u2019s Principles of Immunopharmacology","first-page":"23","article-title":"T Cell Subsets and T Cell-Mediated Immunity","author":"Broere","year":"2019"},{"key":"10.1016\/j.biopha.2024.117177_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1267091","article-title":"The role of inflammation in autoimmune disease: a therapeutic target","volume":"14","author":"Xiang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib7","first-page":"00121","article-title":"Cytokines and their role in health and disease: a brief overview","volume":"4","author":"Gulati","year":"2016","journal-title":"Moj Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri1312","article-title":"NOX enzymes and the biology of reactive oxygen","volume":"4","author":"Lambeth","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110281","article-title":"Thermodynamics of benzoquinone-induced conformational changes in nucleic acids and human serum albumin","volume":"369","author":"Jena","year":"2023","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.biopha.2024.117177_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/cr.2011.13","article-title":"NF-\u03baB in immunobiology","volume":"21","author":"Hayden","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.biopha.2024.117177_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114606","article-title":"Cellular Red-Ox system in health and disease: The latest update","volume":"162","author":"Jena","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.117177_bib12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1568026054985902","article-title":"The Biology of p38 Kinase: A Central Role in Inflammation","volume":"5","author":"Schieven","year":"2005","journal-title":"CTMC"},{"key":"10.1016\/j.biopha.2024.117177_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","article-title":"Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment","volume":"9","author":"Huang","year":"2024","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2024.117177_bib14","article-title":"Reactive-oxygen-species-scavenging nanomaterials for resolving inflammation","volume":"11","author":"Huang","year":"2021","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2024.117177_bib15","doi-asserted-by":"crossref","unstructured":"Sun, Y., Wang, X., Li, L., Zhong, C., Zhang, Y., Yang, X., \u2026 &, Frontiers | The role of gut microbiota in intestinal disease: from an oxidative stress perspective, (2024). \u3008https:\/\/www.frontiersin.org\/journals\/microbiology\/articles\/10.3389\/fmicb.2024.1328324\/full\u3009 (accessed May 2, 2024).","DOI":"10.3389\/fmicb.2024.1328324"},{"key":"10.1016\/j.biopha.2024.117177_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.274","article-title":"Organoids: The current status and biomedical applications","volume":"4","author":"Yang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.biopha.2024.117177_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12951-023-02192-8","article-title":"Advances in photoacoustic imaging aided by nano contrast agents: special focus on role of lymphatic system imaging for cancer theranostics","volume":"21","author":"Sridharan","year":"2023","journal-title":"J. Nanobiotechnol"},{"key":"10.1016\/j.biopha.2024.117177_bib18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive Oxygen Species in Inflammation and Tissue Injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2024.117177_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune Diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2024.117177_bib20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/90935","article-title":"Autoimmune disease: why and where it occurs","volume":"7","author":"Marrack","year":"2001","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2024.117177_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0952-7915(99)00035-7","article-title":"Cytokines that regulate autoimmune responses","volume":"11","author":"Falcone","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib22","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/1529-0131(200007)43:7<1431::AID-ANR3>3.0.CO;2-E","article-title":"Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy","volume":"43","author":"Ioannou","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2024.117177_bib23","doi-asserted-by":"crossref","first-page":"R572","DOI":"10.1016\/S0960-9822(00)00617-5","article-title":"Suppressor T cells: rebirth, function and homeostasis","volume":"10","author":"Shevach","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2024.117177_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0952-7915(00)00228-4","article-title":"J.J. O\u2019Shea, Signaling by type I and II cytokine receptors: ten years after","volume":"13","author":"Gadina","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0031-3955(05)70272-8","article-title":"Autoimmune lymphoproliferative syndrome: a human disorder of abnormal lymphocyte survival","volume":"47","author":"Bleesing","year":"2000","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.biopha.2024.117177_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1074-7613(00)80025-4","article-title":"Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells","volume":"10","author":"Moriggl","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.117177_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1104577","article-title":"Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic","volume":"10","author":"Kumar","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2024.117177_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-065X.1995.tb00092.x","article-title":"Interleukin-2 Deficient Mice: A New Model to Study Autoimmunity and Self-Tolerance","volume":"148","author":"Horak","year":"1995","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2024.117177_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(00)04067-8","article-title":"Relation between occurrence of type 1 diabetes and asthma","volume":"357","author":"Stene","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.117177_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1203\/00006450-200007000-00004","article-title":"Human IL-2 receptor \u03b1 chain deficiency","volume":"48","author":"Roifman","year":"2000","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.biopha.2024.117177_bib31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1046\/j.1365-2141.2000.01923.x","article-title":"Haemophagocytic lymphohistiocytosis in X-linked severe combined immunodeficiency","volume":"108","author":"Grunebaum","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biopha.2024.117177_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/cyto.1999.0609","article-title":"Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene?","volume":"12","author":"Podolin","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2024.117177_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nri702","article-title":"Cytokines and autoimmunity","volume":"2","author":"O\u2019Shea","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/BOR.0000000000000594","article-title":"Pathogenesis and treatment of autoimmune rheumatic diseases","volume":"31","author":"Liu","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.biopha.2024.117177_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000336","article-title":"Type I interferons in host defence and inflammatory diseases","volume":"6","author":"Crow","year":"2019","journal-title":"Lupus Sci. Med"},{"key":"10.1016\/j.biopha.2024.117177_bib36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.mib.2008.05.015","article-title":"Tumor necrosis factor and interferon: cytokines in harmony","volume":"11","author":"Bartee","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.biopha.2024.117177_bib37","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI12724","article-title":"Severe inflammatory arthritis and lymphadenopathy in the absence of TNF","volume":"107","author":"Campbell","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2024.117177_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1074-7613(00)80198-3","article-title":"The temporal importance of TNF\u03b1 expression in the development of diabetes","volume":"12","author":"Green","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.117177_bib39","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.4049\/jimmunol.166.9.5530","article-title":"IFN-\u03b1 and IL-10 induce the differentiation of human type 1 T regulatory cells","volume":"166","author":"Levings","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib40","doi-asserted-by":"crossref","first-page":"15137","DOI":"10.1073\/pnas.261570598","article-title":"J.J. O\u2019Shea, T-bet is rapidly induced by interferon-\u03b3 in lymphoid and myeloid cells","volume":"98","author":"Lighvani","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2024.117177_bib41","first-page":"1","article-title":"Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain","volume":"521","author":"Watkins","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2024.117177_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","article-title":"Pain and immunity: implications for host defence","volume":"19","author":"Baral","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib43","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1172\/JCI42843","article-title":"Nociceptors: the sensors of the pain pathway","volume":"120","author":"Dubin","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2024.117177_bib44","article-title":"Brainstem Pain-Modulation Circuitry and Its Plasticity in Neuropathic Pain: Insights From Human Brain Imaging Investigations","volume":"2","author":"Mills","year":"2021","journal-title":"Front. Pain. Res."},{"key":"10.1016\/j.biopha.2024.117177_bib45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.neuroscience.2006.06.045","article-title":"Robust increase of cutaneous sensitivity, cytokine production and sympathetic sprouting in rats with localized inflammatory irritation of the spinal ganglia","volume":"142","author":"Xie","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2024.117177_bib46","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1002\/eji.1830221131","article-title":"Expression of interleukin (IL)-1\u03b2, IL-6 and their respective receptors in the normal rat brain and after injury","volume":"22","author":"Yan","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-5728(01)00324-1","article-title":"Expression of interleukin-1 beta in rat dorsal root ganglia","volume":"118","author":"Copray","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2024.117177_bib48","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0028-3908(94)90171-6","article-title":"Interleukin-1\u03b2 induced-desArg9bradykinin-mediated thermal hyperalgesia in the rat","volume":"33","author":"Perkins","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2024.117177_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","article-title":"Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease","volume":"172","author":"Boka","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2024.117177_bib50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-\u03b2, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117177_bib51","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1172\/JCI80883","article-title":"Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-\u03b2 secretion","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2024.117177_bib52","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1523\/JNEUROSCI.21-14-05027.2001","article-title":"Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons","volume":"21","author":"Oh","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2024.117177_bib53","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.0503496102","article-title":"Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion","volume":"102","author":"White","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2024.117177_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1529-8027.2000.00009.x","article-title":"Increased expression of chemokines (MCP-1, MIP-1\u03b1, RANTES) after peripheral nerve transection","volume":"5","author":"Taskinen","year":"2000","journal-title":"J. Peripher. Nerv. Sys"},{"key":"10.1016\/j.biopha.2024.117177_bib55","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.1331358100","article-title":"Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2","volume":"100","author":"Abbadie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2024.117177_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cne.2000","article-title":"Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment","volume":"439","author":"Winkelstein","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2024.117177_bib57","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1152\/physrev.00011.2002","article-title":"Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States","volume":"82","author":"Watkins","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2024.117177_bib58","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.ejim.2016.06.019","article-title":"Ulcerative colitis: A scientometric approach to the global research output and network","volume":"34","author":"Sch\u00f6ffel","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.biopha.2024.117177_bib59","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn\u2019s disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.117177_bib60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm0602-567","article-title":"The role of Th1\/Th2 polarization in mucosal immunity","volume":"8","author":"Neurath","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2024.117177_bib61","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ibd.21417","article-title":"Long-term complications, extraintestinal manifestations, and mortality in adult Crohn\u2019s disease in population-based cohorts","volume":"17","author":"Peyrin-Biroulet","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib62","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/ibd.21590","article-title":"Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn\u2019s disease","volume":"17","author":"Ng","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib63","first-page":"2434","article-title":"Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation","volume":"154","author":"Casini-Raggi","year":"1995","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"key":"10.1016\/j.biopha.2024.117177_bib64","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20111453","article-title":"IL-1\u03b2 mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells","volume":"209","author":"Coccia","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2024.117177_bib65","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1053\/j.gastro.2005.01.013","article-title":"Colitis in mice lacking the common cytokine receptor \u03b3 chain is mediated by IL-6-producing CD4+ T cells","volume":"128","author":"Kai","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.117177_bib66","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.4049\/jimmunol.164.9.4878","article-title":"IL-6 is required for the development of Th1 cell-mediated murine colitis","volume":"164","author":"Yamamoto","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib67","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117177_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/mi.2013.60","article-title":"Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells","volume":"7","author":"Bishop","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib70","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1053\/j.gastro.2011.08.032","article-title":"Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14+ macrophages","volume":"141","author":"Atreya","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.117177_bib71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature10400","article-title":"Caspase-8 regulates TNF-\u03b1-induced epithelial necroptosis and terminal ileitis","volume":"477","author":"G\u00fcnther","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117177_bib72","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ibd.20051","article-title":"Effect of the anti-tumor necrosis factor-\u03b1 antibody infliximab on the ex vivo mucosal matrix metalloproteinase\u2013proteolytic phenotype in inflammatory bowel disease","volume":"13","author":"Meijer","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib73","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.gastro.2013.04.011","article-title":"TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis","volume":"145","author":"Su","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2024.117177_bib74","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.4049\/jimmunol.1301093","article-title":"Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell\u2013mediated colitis","volume":"191","author":"Kole","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib75","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI22996","article-title":"Toll-like receptor 9\u2013induced type I IFN protects mice from experimental colitis","volume":"115","author":"Katakura","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2024.117177_bib76","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ibd.23019","article-title":"Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity","volume":"19","author":"Musch","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.117177_bib78","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2024.117177_bib79","first-page":"5132","article-title":"Proliferative activity of intratumoral CD8+ T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity","volume":"61","author":"Nakano","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.117177_bib80","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2024.117177_bib81","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.191.4.661","article-title":"Differential tumor surveillance by natural killer (NK) and NKT cells","volume":"191","author":"Smyth","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2024.117177_bib82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2024.117177_bib83","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117177_bib84","first-page":"192","article-title":"Perforin and interferon-\u03b3 activities independently control tumor initiation, growth, and metastasis, Blood","volume":"97","author":"Street","year":"2001","journal-title":"J. Am. Soc. Hematol."},{"key":"10.1016\/j.biopha.2024.117177_bib85","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20011887","article-title":"Inhibition of Methylcholanthrene-induced Carcinogenesis by an Interferon \u03b3 Receptor\u2013dependent Foreign Body Reaction","volume":"195","author":"Qin","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2024.117177_bib86","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFN\u03b3 and lymphocytes prevent primary tumour development and shape tumour immunogenicity","volume":"410","author":"Shankaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117177_bib87","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","article-title":"Targeting inflammation in the treatment of type 2 diabetes: time to start","volume":"13","author":"Donath","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.117177_bib88","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s001250051058","article-title":"Is Type II diabetes mellitus a disease of the innate immune system?","volume":"41","author":"Pickup","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2024.117177_bib89","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","article-title":"Targeting innate immune mediators in type 1 and type 2 diabetes","volume":"19","author":"Donath","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003770","article-title":"Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn\u2019s disease","volume":"9","author":"Carbonetto","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.biopha.2024.117177_bib91","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.117177_bib92","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3422","article-title":"Type 1 diabetes: translating mechanistic observations into effective clinical outcomes","volume":"13","author":"Herold","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1900\/RDS.2009.6.85","article-title":"Histopathology of type 1 diabetes: old paradigms and new insights","volume":"6","author":"Coppieters","year":"2009","journal-title":"Rev. Diabet. Stud.: RDS"},{"key":"10.1016\/j.biopha.2024.117177_bib94","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-5728(00)00388-X","article-title":"A. Larsson, IL-10 and IFN-\u03b3 in Guillain\u2013Barr\u00e9 syndrome","volume":"112","author":"Press","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2024.117177_bib95","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2174\/0929867033456918","article-title":"Role of cytokines in neurological disorders","volume":"10","author":"Aarli","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2024.117177_bib96","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1034\/j.1600-0404.2002.1o199.x","article-title":"Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis: Correlation of cytokines and MRI in multiple sclerosis","volume":"105","author":"Kraus","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.biopha.2024.117177_bib97","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/WNL.59.2.287","article-title":"Increased serum levels of the interferon-\u03b3\u2013inducing cytokine interleukin-18 in myasthenia gravis","volume":"59","author":"Jander","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2024.117177_bib98","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/1389450043345308","article-title":"Cytokines in neuroinflammation and Alzheimer\u2019s disease","volume":"5","author":"Cacquevel","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2024.117177_bib99","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(02)00300-2","article-title":"Association of interleukin-1\u03b2 polymorphisms with idiopathic Parkinson\u2019s disease","volume":"326","author":"McGeer","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2024.117177_bib100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1471-4159.2002.00799.x","article-title":"The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-\u03b1, IL-1\u03b2 and IFN-\u03b3","volume":"81","author":"Casta\u00f1o","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2024.117177_bib101","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"J.P. O\u2019Callaghan, Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson\u2019s disease","volume":"16","author":"Sriram","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2024.117177_bib102","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2741\/2713","article-title":"Neuroinflammation in Parkinson\u2019s disease: is there sufficient evidence for mechanism-based interventional therapy?","volume":"13","author":"Tansey","year":"2008","journal-title":"Front. Biosci. -Landmark"},{"key":"10.1016\/j.biopha.2024.117177_bib103","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0735-1097(99)00600-2","article-title":"The role of tumor necrosis factor in the pathophysiology of heart failure","volume":"35","author":"Feldman","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2024.117177_bib104","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0735-1097(01)01377-8","article-title":"Nuclear factor kappa-B and the heart","volume":"38","author":"Valen","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2024.117177_bib105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","article-title":"Fibrosis in heart disease: understanding the role of transforming growth factor-\u03b2 1 in cardiomyopathy, valvular disease and arrhythmia","volume":"118","author":"Khan","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2024.117177_bib106","first-page":"3720","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.biopha.2024.117177_bib107","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1011428824771","article-title":"C.S. Long, The role of interleukin-1 in the failing heart","volume":"6","year":"2001","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2024.117177_bib108","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cytogfr.2006.07.003","article-title":"Both integrated and differential regulation of components of the IL-2\/IL-2 receptor system","volume":"17","author":"Kim","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2024.117177_bib109","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib110","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.cellsig.2012.12.008","article-title":"p42\/p44-MAPK and PI3K are sufficient for IL-6 family cytokines\/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK\/STAT activation","volume":"25","author":"Fahmi","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biopha.2024.117177_bib111","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"10.1016\/j.biopha.2024.117177_bib112","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2024.117177_bib113","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1038\/s41598-024-59344-5","article-title":"The relationship between cardiac oxidative stress, inflammatory cytokine response, cardiac pump function, and prognosis post-myocardial infarction","volume":"14","author":"Duan","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117177_bib114","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/JIR.S275595","article-title":"Reactive Oxygen Species: Drivers of Physiological and Pathological Processes","volume":"Volume 13","author":"Checa","year":"2020","journal-title":"JIR"},{"key":"10.1016\/j.biopha.2024.117177_bib115","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/antiox12101812","article-title":"Role of Oxidative Stress and Inflammation in Gestational Diabetes Mellitus","volume":"12","author":"Saucedo","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2024.117177_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.10.049","article-title":"Cytokines and anti-cytokines as therapeutics\u2014An update","volume":"579","author":"Tayal","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117177_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.692142","article-title":"Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis","volume":"11","author":"Kartikasari","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2024.117177_bib118","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0165-6147(02)02064-3","article-title":"Chemokines, chemokine receptors and small-molecule antagonists: recent developments","volume":"23","author":"Onuffer","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2024.117177_bib119","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2146\/ajhp070449","article-title":"Tocilizumab: the first interleukin-6-receptor inhibitor","volume":"65","author":"Sebba","year":"2008","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.biopha.2024.117177_bib120","first-page":"851","article-title":"Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth","volume":"53","author":"Sato","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.117177_bib121","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.intimp.2005.05.010","article-title":"Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family","volume":"5","author":"Mihara","year":"2005","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.117177_bib122","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejim.2020.05.021","article-title":"Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study","volume":"76","author":"Campochiaro","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.biopha.2024.117177_bib123","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1093\/cid\/ciaa954","article-title":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19","volume":"73","author":"Somers","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib124","article-title":"Sarilumab, a subcutaneously-administered, fully-human monoclonal antibody inhibitor of the IL-6 receptor: Effects on hemoglobin levels in a clinical trial for the treatment of moderate-to-severe rheumatoid arthritis","volume":"64","author":"Genovese","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2024.117177_bib125","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/jmv.26062","article-title":"COVID-19 pneumonia treated with sarilumab: a clinical series of eight patients","volume":"92","author":"Benucci","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.biopha.2024.117177_bib126","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117177_bib127","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2013-205137","article-title":"Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13054-020-03020-3","article-title":"Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients","volume":"24","author":"Convertino","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.biopha.2024.117177_bib129","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/ard.2008.089375","article-title":"Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study","volume":"68","author":"Mease","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/ard.61.4.311","article-title":"Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation","volume":"61","author":"Den Broeder","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib131","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF antibody","volume":"30","author":"Knight","year":"1993","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib132","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor \u03b1 for Crohn\u2019s Disease","volume":"337","author":"Targan","year":"1997","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2024.117177_bib133","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/ard.2003.013961","article-title":"Infliximab in active early rheumatoid arthritis","volume":"63","author":"Breedveld","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib134","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.117177_bib135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Behcet\u2019s disease","volume":"358","author":"Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.117177_bib136","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4155\/ppa-2016-0043","article-title":"Enbrel and etanercept biosimilars: a tale of two patent systems","volume":"6","author":"Norman","year":"2017","journal-title":"Pharm. Pat. Anal."},{"key":"10.1016\/j.biopha.2024.117177_bib137","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pbc.21019","article-title":"Etanercept for therapy-resistant macrophage activation syndrome","volume":"50","author":"Makay","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.biopha.2024.117177_bib138","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/s10165-011-0477-9","article-title":"Adult-onset Still\u2019s disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept","volume":"22","author":"Maeshima","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.biopha.2024.117177_bib139","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3389\/fphar.2018.01157","article-title":"Anakinra Therapy for Non-cancer Inflammatory Diseases","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117177_bib141","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4161\/mabs.3.1.13989","article-title":"XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1\u03b2-mediated diseases","volume":"3","author":"Owyang","year":"2011","journal-title":"mAbs"},{"key":"10.1016\/j.biopha.2024.117177_bib142","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12016-014-8455-6","article-title":"The Use of Biologic Therapies in Uveitis","volume":"49","author":"Schwartzman","year":"2015","journal-title":"Clin. Rev. Allerg. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib143","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/annrheumdis-2011-155143","article-title":"Interleukin-1\u03b2-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Beh\u00e7et\u2019s disease: an open-label pilot study","volume":"71","author":"G\u00fcl","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib144","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2337\/dc11-2219","article-title":"Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes","volume":"35","author":"Cavelti-Weder","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2024.117177_bib145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","article-title":"Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients","volume":"50","author":"Miettunen","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2024.117177_bib146","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237525","article-title":"Cytokine storm and use of anakinra in a patient with COVID-19","volume":"13","author":"Nemchand","year":"2020","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.biopha.2024.117177_bib147","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-9255-7-41","article-title":"Anti-inflammatory activity and neutrophil reductions mediated by the JAK1\/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis","volume":"7","author":"Meyer","year":"2010","journal-title":"J. Inflamm."},{"key":"10.1016\/j.biopha.2024.117177_bib148","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.113.209304","article-title":"Preclinical to Clinical Translation of Tofacitinib, a Janus Kinase Inhibitor, in Rheumatoid Arthritis","volume":"348","author":"Dowty","year":"2014","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2024.117177_bib149","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1158\/1078-0432.CCR-11-3145","article-title":"Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosis","volume":"18","author":"Mascarenhas","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.117177_bib150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaci.2020.05.019","article-title":"Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial","volume":"146","author":"Cao","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib151","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2024.117177_bib152","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40265-018-1046-8","article-title":"Emapalumab: First Global Approval","volume":"79","author":"Al-Salama","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2024.117177_bib153","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/bcp.15133","article-title":"Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model-based approach","volume":"88","author":"Jacqmin","year":"2022","journal-title":"Brit J. Clin. Pharma"},{"key":"10.1016\/j.biopha.2024.117177_bib154","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1182\/bloodadvances.2018025858","article-title":"Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections","volume":"3","author":"Lounder","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.biopha.2024.117177_bib155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41577-020-0346-x","article-title":"Dysregulation of type I interferon responses in COVID-19","volume":"20","author":"Acharya","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib156","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40265-016-0602-3","article-title":"Secukinumab: A Review in Psoriatic Arthritis","volume":"76","author":"Shirley","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2024.117177_bib157","article-title":"COVID-19 in an elderly patient treated with secukinumab","volume":"33","author":"Di Lernia","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.biopha.2024.117177_bib158","first-page":"13","article-title":"Process for the preparation of quinoline compounds containing amino groups with basic substituents in the 4-position","author":"Andersag","year":"1939","journal-title":"Pat. DE 683692"},{"key":"10.1016\/j.biopha.2024.117177_bib159","doi-asserted-by":"crossref","unstructured":"L.M.H. da Mota, A.M. Kakehasi, A.P.M. Gomides, A.L.B.P. Duarte, B.A. Cruz, C.V. Brenol, C.P. de Albuquerque, G. da R.C. Pinheiro, I.A. Pereira, M.B. Bertolo, 2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis, Advances in Rheumatology 58 (2019). \u3008https:\/\/www.scielo.br\/j\/adr\/a\/HYbD45fZzrCq84gkcTKMvDg\/?lang=en\u3009 (accessed February 4, 2024).","DOI":"10.1186\/s42358-018-0005-0"},{"key":"10.1016\/j.biopha.2024.117177_bib160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2024.117177_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105982","article-title":"Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies","volume":"55","author":"Zhao","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2024.117177_bib162","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41598-021-81462-7","article-title":"Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies","volume":"11","author":"Jena","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117177_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113890","article-title":"An in silico investigation on the interactions of curcumin and epigallocatechin-3-gallate with NLRP3 Inflammasome complex","volume":"156","author":"Jena","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2024.117177_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2022.106828","article-title":"CTK7A, a curcumin derivative, can be a potential candidate for targeting HIF-1\u03b1\/p300 complex: Evidences from in vitro and computational studies","volume":"287","author":"Rath","year":"2022","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.biopha.2024.117177_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570122","article-title":"Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19","volume":"11","author":"Mrityunjaya","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib166","series-title":"Nutraceuticals and Functional Foods in Immunomodulators","first-page":"291","article-title":"Immune Booster Property of Epigallocatechin-3-Gallate and Catechin","author":"Valencia-Hern\u00e1ndez","year":"2022"},{"key":"10.1016\/j.biopha.2024.117177_bib167","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43014-023-00133-4","article-title":"A review on the immunomodulatory properties of functional nutraceuticals as dietary interventions for children to combat COVID-19 related infections","volume":"5","author":"Soni","year":"2023","journal-title":"Food Prod. Process Nutr."},{"key":"10.1016\/j.biopha.2024.117177_bib168","unstructured":"A. Ganeshpurkar, A. Saluja, Immunomodulatory effect of rutin, catechin, and hesperidin on macrophage function, (2020). \u3008https:\/\/nopr.niscpr.res.in\/handle\/123456789\/54048\u3009 (accessed February 6, 2024)."},{"key":"10.1016\/j.biopha.2024.117177_bib169","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3390\/nu13072232","article-title":"Therapeutic effects of catechins in less common neurological and neurodegenerative disorders","volume":"13","author":"Sebastiani","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.117177_bib170","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/jn\/137.10.2190","article-title":"Dietary flavones and flavonoles are inhibitors of poly (ADP-ribose) polymerase-1 in pulmonary epithelial cells","volume":"137","author":"Geraets","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2024.117177_bib171","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jnr.21503","article-title":"Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation","volume":"86","author":"Bureau","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2024.117177_bib172","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1021\/jf903698s","article-title":"Protective Effect of Quercetin against Arsenite-Induced COX-2 Expression by Targeting PI3K in Rat Liver Epithelial Cells","volume":"58","author":"Lee","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2024.117177_bib173","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/v8010006","article-title":"Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry","volume":"8","author":"Wu","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2024.117177_bib174","doi-asserted-by":"crossref","unstructured":"M.L. Van Driel, E.M. Beller, E. Thielemans, L. Deckx, E. Price-Haywood, J. Clark, A.I. De Sutter, Oral vitamin C supplements to prevent and treat acute upper respiratory tract infections, The Cochrane Database of Systematic Reviews 2019 (2019). \u3008https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6424584\/\u3009 (accessed February 6, 2024).","DOI":"10.1002\/14651858.CD013292"},{"key":"10.1016\/j.biopha.2024.117177_bib175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12263-019-0636-8","article-title":"Herbs and Spices- Biomarkers of Intake Based on Human Intervention Studies \u2013 A Systematic Review","volume":"14","author":"V\u00e1zquez-Fresno","year":"2019","journal-title":"Genes Nutr."},{"key":"10.1016\/j.biopha.2024.117177_bib176","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.freeradbiomed.2011.05.017","article-title":"Vitamins C and E: beneficial effects from a mechanistic perspective","volume":"51","author":"Traber","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2024.117177_bib177","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3389\/fimmu.2020.01451","article-title":"Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19)","volume":"11","author":"Colunga Biancatelli","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117177_bib178","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2012.07.007","article-title":"Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature","volume":"12","author":"Antico","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2024.117177_bib179","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.fct.2015.05.022","article-title":"The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update","volume":"83","author":"Ghosh","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2024.117177_bib180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/biology8020030","article-title":"Vitamin D deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging","volume":"8","author":"Wimalawansa","year":"2019","journal-title":"Biology"},{"key":"10.1016\/j.biopha.2024.117177_bib181","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.3390\/nu7031933","article-title":"Vitamin D status and acute respiratory infection: cross sectional results from the United States National Health and Nutrition Examination Survey, 2001\u20132006","volume":"7","author":"Monlezun","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.117177_bib182","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jgs.14679","article-title":"High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial","volume":"65","author":"Ginde","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.biopha.2024.117177_bib183","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/dvdy.21677","article-title":"Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease","volume":"238","author":"Liao","year":"2009","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.biopha.2024.117177_bib184","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.clnu.2004.03.011","article-title":"Y. Chowers, Allicin inhibits spontaneous and TNF-\u03b1 induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells","volume":"23","author":"Lang","year":"2004","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.biopha.2024.117177_bib185","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.fct.2013.04.002","article-title":"Short-term heating reduces the anti-inflammatory effects of fresh raw garlic extracts on the LPS-induced production of NO and pro-inflammatory cytokines by downregulating allicin activity in RAW 264.7 macrophages","volume":"58","author":"Shin","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2024.117177_bib186","unstructured":"A.S. Galabov, Virucidal agents in the eve of manorapid synergy\u00ae, GMS Krankenhaushygiene Interdisziplinar 2 (2007). \u3008https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2831485\/\u3009 (accessed February 6, 2024)."},{"key":"10.1016\/j.biopha.2024.117177_bib187","doi-asserted-by":"crossref","unstructured":"K. Wolska, A. Gorska, K. Antosik, K. \\Lugowska, Immunomodulatory Effects of Propolis and its Components on Basic Immune Cell Functions., Indian Journal of Pharmaceutical Sciences 81 (2019). \u3008https:\/\/www.researchgate.net\/profile\/Wolska-Katarzyna\/publication\/335110125_IJPS-Wolska_propolis\/links\/5d51135aa6fdcc370a8eceab\/IJPS-Wolska-propolis.pdf\u3009 (accessed February 6, 2024).","DOI":"10.36468\/pharmaceutical-sciences.548"},{"key":"10.1016\/j.biopha.2024.117177_bib188","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jep.2010.10.032","article-title":"Propolis: is there a potential for the development of new drugs?","volume":"133","author":"Sforcin","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.117177_bib189","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/00071660601050755","article-title":"Holo-analysis of the efficacy of Bio-Mos\u00ae in broiler nutrition","volume":"48","author":"Rosen","year":"2007","journal-title":"Br. Poult. Sci."},{"key":"10.1016\/j.biopha.2024.117177_bib190","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1021\/np50107a013","article-title":"Comparison of the Anti-Herpes Simplex Virus Activities of Propolis and 3-Methyl-but-2-enyl Caffeate","volume":"57","author":"Amoros","year":"1994","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2024.117177_bib191","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3390\/ijms18091985","article-title":"Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis","volume":"18","author":"Rosa","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.117177_bib192","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1248\/bpb.28.1717","article-title":"Liposomalization of lactoferrin enhanced it\u2019s anti-inflammatory effects via oral administration","volume":"28","author":"Ishikado","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2024.117177_bib193","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4103\/1735-5362.192488","article-title":"Protective effect of Melissa officinalis extract against H2O2-induced oxidative stress in human vascular endothelial cells","volume":"11","author":"Safaeian","year":"2016","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.biopha.2024.117177_bib194","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10571-015-0166-x","article-title":"Ros and autophagy: interactions and molecular regulatory mechanisms","volume":"35","author":"Li","year":"2015","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2024.117177_bib195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12944-023-01782-7","article-title":"In silico profiling of nonsynonymous SNPs of fat mass and obesity-associated gene: possible impacts on the treatment of non-alcoholic fatty liver disease","volume":"22","author":"Patnaik","year":"2023","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2024.117177_bib196","series-title":"Characterisation and Design of Tissue Scaffolds","first-page":"149","article-title":"Characterization of tissue scaffolds drug release profiles","author":"Prabaharan","year":"2016"},{"key":"10.1016\/j.biopha.2024.117177_bib197","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2024.117177_bib198","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between a\u03b2 and tau in the pathogenesis of alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2024.117177_bib199","first-page":"709","article-title":"Cytokines and radiation-induced pulmonary injuries","volume":"59","author":"Lierova","year":"2018","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.biopha.2024.117177_bib200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tips.2017.11.003","article-title":"Cancer radiosensitizers","volume":"39","author":"Wang","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2024.117177_bib201","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s10495-017-1424-9","article-title":"Induction of reactive oxygen species: an emerging approach for cancer therapy","volume":"22","author":"Zou","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.biopha.2024.117177_bib202","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5694\/mja2.12046","article-title":"Radiotherapy and immunotherapy: a synergistic effect in cancer care","volume":"210","author":"Turgeon","year":"2019","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.biopha.2024.117177_bib203","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41565-022-01261-7","article-title":"Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics","volume":"18","author":"Shi","year":"2023","journal-title":"Nat. Nanotechnol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224010618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:57:16Z","timestamp":1777863436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224010618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":203,"alternative-id":["S0753332224010618"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117177","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117177"}}